Recombinant human brain natriuretic peptide (Tibet Rhodiola)
重组人脑利钠肽 (西藏诺迪康生物)
Report date: 2026/05/25 20:02:40
Base Information
Drug NameRecombinant human brain natriuretic peptide (Tibet Rhodiola)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved Indications
Approved Indications in China
Original Approved Country/Territory
Original Approved Date2005/04/11
Country/Territory
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesTibet Rhodiola Pharmaceutical Holding Company
China Registration ClassClass 1 therapeutic biologic in China
Develop Information
Active CompaniesChengdu Rhodiola Bio-Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active Indications
Inactive IndicationsN/A
Other Information
ATC Code
Related LinksN/A